Further understanding of the broader importance of this pathway both to allergic airway inflammation and more chronic respiratory conditions typified by neutrophilic inflammation (e.g., chronic obstructive pulmonary disease) is also required particularly given the current therapeutic interest in blocking IL-4 signaling responses to limit disease progression. This evidence concerns the gene IL4 and chronic obstructive pulmonary disease.